Category:Dopamine agonists

From Wikipedia, the free encyclopedia

Jump to: navigation, search

These agents stimulate dopamine receptors. In doing so, they alleviate the symptoms associated with Parkinson's disease.

Wikimedia Commons has media related to: Dopamine agonists

The main article for this category is Dopamine agonist.

Subcategories

This category has only the following subcategory.

D

• ► D1-receptor agonists‎ (2 P)

Pages in category "Dopamine agonists"

The following 72 pages are in this category, out of 72 total. This list may not reflect recent changes (learn more).

List of dopaminergic drugs * Dopamine agonist 2 2-OH-NPA 6 6-Br-APB 8 8-OH-PBZI A A-412,997 A-68930 A-77636 A-86929 ABT-670 ABT-724 Amphetamine Aplindore Apomorphine Apomorphine (data page) Azapride B BP-897 Brexpiprazole Bromocriptine C Cabergoline Cathinone Ciladopa CP-226,269 CY-208,243

D Dihydrexidine Dihydroergocryptine Dinapsoline Dinoxyline Dopaminergic Dopexamine Doxanthrine E Epicriptine Etilevodopa F Fencamfamine 4-Fluoromethamphetamine 3-Fluoromethcathinone G GSK-789,472 L Lisuride M Mefway (18F) Melevodopa Mesulergine Metergoline Methamphetamine Mephedrone O 5-OH-DPAT 7-OH-DPAT OSU-6162 P PD-128,907

P cont. PD-168,077 Pergolide PF-219,061 Piribedil Pramipexole Propylhexedrine Propylnorapomorphine Q Quinelorane R RDS-127 Ro10-5824 Ropinirole Rotigotine S SKF-38,393 SKF-77,434 SKF-81,297 SKF-82,958 SKF-83,959 SKF-89,145 Stepholidine Sumanirole T Talipexole TAN-67 Terguride W WAY-100,635

Retrieved from "http://en.wikipedia.org/w/index.php?title=Category:Dopamine_agonists&oldid=434370814"

Categories:

• Receptor agonists
• Antiparkinsonian agents
• Psychoactive drugs

• This page was last modified on 15 June 2011 at 07:35.
  
• Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. See Terms of use for details.
  Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.
  
• Contact us

• Privacy policy
• About Wikipedia
• Disclaimers
• Mobile view